Gene · 6523
Papers3,836
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,836
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A network meta-analysis of safety and efficacy of sodium-glucose cotransporter 2 inhibitors in heart failure patients. | Ann Med Surg (Lond) | 2026 | 41789221 | PubTator, text mining | PubMed |
| Comparative Efficacy of SGLT2 Inhibitors in MASLD: Bayesian Network Meta-Analysis of CAP-LSM Outcomes and Time Effects. | JGH Open | 2026 | 41782609 | PubTator, text mining | PubMed |
| Risk of Dementia in Patients With Type 2 Diabetes Using SGLT2 Inhibitors Versus DPP-4 Inhibitors: A Systematic Review and Meta-Analysis. | Endocrinol Diabetes Metab | 2026 | 41777041 | PubTator, text mining | PubMed |
Antidiabetic Effect of Phanera strychnifolia (Craib) K. W. Jiang, S. R. Gu, & T. Y. Tu Extracts in Streptozotocin-Induced Diabetic Rats by Upregulating Insulin Secretion and Glucose Transporter 2 and 4 Protein Expression. | Scientifica (Cairo) | 2026 | 41767126 | PubTator, text mining | PubMed |
| The SGLT2 inhibitor checklist: a comprehensive review of perioperative and acute phase safety management. | Front Endocrinol (Lausanne) | 2026 | 41757229 | PubTator, text mining | PubMed |
| Impact of sodium alginate energy gel on the marathon performance of amateur runners: a randomized controlled study. | Front Physiol | 2026 | 41755891 | PubTator, text mining | PubMed |
| Carbohydrate Storage and Supplementation Strategies for Peak Performance in Cross-Country Skiing. | Scand J Med Sci Sports | 2026 | 41755452 | PubTator, text mining | PubMed |
| Posidonia oceanica (L.) Delile in Focus: In Vitro and In Vivo Evidence for Biomedical Potential. | Int J Mol Sci | 2026 | 41751863 | PubTator, text mining | PubMed |
| Mechanisms of SGLT inhibitor action and physiological mediators: systematic review and protocol for the MOSAIC collaborative meta-analysis. | BMJ Open | 2026 | 41748173 | PubTator, text mining | PubMed |
| Electrochemical Sensors as a Tool for Taste Perception in Pharmaceutical Products: Advances and Perspectives. | Biosensors (Basel) | 2026 | 41744703 | PubTator, text mining | PubMed |
| Alternative methods for pharmacological research on the action mechanisms of natural products used in the treatment of type 2 diabetes: a systematic review. | Front Pharmacol | 2026 | 41743124 | PubTator, text mining | PubMed |
| Drug repurposing of ticagrelor suppresses renal cell carcinoma growth by blockading the EGFR/PI3K/AKT axis. | Ann Med | 2026 | 41741334 | PubTator, text mining | PubMed |
| Sodium-glucose cotransporter-2 inhibitors lower risk of kidney replacement therapy and mortality in bipolar disorder with chronic kidney disease. | Ther Adv Psychopharmacol | 2026 | 41732711 | PubTator, text mining | PubMed |
| Post-COVID Syndrome in Patients With Comorbid Hypertension or Diabetes: A Narrative Review of Long-Term Outcomes. | Cureus | 2026 | 41732619 | PubTator, text mining | PubMed |
| Research on the correlation and potential mechanism of PKCδ expression with efficacy and prognosis in diffuse large B-cell lymphoma. | Front Oncol | 2026 | 41727647 | PubTator, text mining | PubMed |
| Medicinal chemistry advances of SGLT inhibitors: SAR, structural innovation, and mechanistic insights. | Eur J Med Chem | 2026 | 41722433 | PubTator, text mining | PubMed |
| Glycemic Impact of Non-Nutritive Sweeteners in Health and Type 2 Diabetes. | Nutr Rev | 2026 | 41706019 | PubTator, text mining | PubMed |
| Dose- and Time-Dependent Effects of Cobalt Chloride Supplementation on Growth Performance and Intestinal Development in Weaned Piglets. | Animals (Basel) | 2026 | 41681421 | PubTator, text mining | PubMed |
| Functional characterization of peptides from Acheta domesticus proteins: intestinal transport, cytotoxicity, and gene expression modulation in Caco-2 cells. | Int J Biol Macromol | 2026 | 41651262 | PubTator, text mining | PubMed |
| Re-engineering insulin for oral delivery: structural modifications, advanced formulation strategies, and future directions. | Drug Deliv | 2026 | 41642241 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6523/papers?page=3